Diederik Stapel is up to 54 retractions.
Here’s the notice from Self and Identity: Continue reading Measure by measure: Diederik Stapel count rises again, to 54
Category: faked data
Journal of Neuroscience retracts plasticity paper for “substantial data misrepresentation”
The Journal of Neuroscience has retracted a 2012 paper by a group from Sweden’s Karolinska Institutet for what appears to be research misconduct. But more on that in a moment.
The article, “The Existence of FGFR1-5-HT1A Receptor Heterocomplexes in Midbrain 5-HT Neurons of the Rat: Relevance for Neuroplasticity,” came from the lab of Kjell Fuxe, whose interests include Parkinson’s disease, addiction and depression. The first and second authors, Dasiel Oscar Borroto-Escuela and Wilber Romero-Fernandez, are listed as being post-docs in the lab.
According to the notice: Continue reading Journal of Neuroscience retracts plasticity paper for “substantial data misrepresentation”
Retractions arrive for former Wash U neuroscience grad student found to have committed misconduct
Two studies by Adam Savine, the former Washington University neuroscience graduate student found by the Office of Research Integrity to have falsified data, have been retracted.
Here’s the notice for one: Continue reading Retractions arrive for former Wash U neuroscience grad student found to have committed misconduct
Autism genetics papers retracted after fraud inquiry at NY research agency
A fraud investigation at a New York state research institution has led to two retractions of papers looking at genetic links to autism.
The 2011 papers, which appeared in Genes, Brain and Behavior, involve work conducted at the New York State Office for People With Developmental Disabilities’ (OPWDD’s) Institute for Basic Research in Developmental Disabilities, on Staten Island. The last author on both articles is Xiaohong Li, head of the institute’s cellular neurobiology laboratory.
Here’s what the retraction notice has to say: Continue reading Autism genetics papers retracted after fraud inquiry at NY research agency
Glaxo asks Nature Medicine to retract paper by fired company scientist
In what could be a significant blow to a major pharmaceutical company, Nature Medicine is reportedly set to retract a 2010 article by a group of researchers affiliated with a Chinese arm of the drug giant GlaxoSmithKline.
We’re not the first to report the news — you can read coverage of it on In the Pipeline and Pharmalot, for starters — which includes the revelation that Glaxo has fired Jingwu Zang, a co-author of the suspect paper and former senior vice president and head of research and development at the Shanghai facility: in other words, a big fish. (Big enough to have a profile in, well, Nature Reviews Drug Discovery.)
Pharmalot has quoted a Glaxo spokeswoman: Continue reading Glaxo asks Nature Medicine to retract paper by fired company scientist
A partial retraction appears for former Salzburg crystallographer who admitted misconduct
A paper by a crystallographer fired from his university for misconduct has been partially retracted.
Last year, we covered the case of Robert Schwarzenbacher, formerly of Salzburg University. Schwarzenbacher had provided the crystallographic data for a paper in the Journal of Immunology, but those results raised questions with another crystallographer and prompted an investigation by the university. Schwarzenbacher admitted he’d committed misconduct, although he recanted at one point, and was eventually fired.
Now, the authors have retracted the crystallographic data from the Journal of Immunology paper. Here’s the partial retraction, which is listed as a correction:
Continue reading A partial retraction appears for former Salzburg crystallographer who admitted misconduct
Cardiology journals retract five Matsubara studies
The American Heart Association (AHA) is retracting five studies by Hiroaki Matsubara, a former Kyoto Prefectural University cardiology researcher, that it had subjected to an expression of concern last year.
Here’s the notice: Continue reading Cardiology journals retract five Matsubara studies
A retraction with “serious consequences to wheat production”
Chinese researchers have had a 2012 paper in Plant Molecular Biology Reporter on genetically modified wheat retracted, in a notice that cites fraud.
The article, “Isolation and Functional Characterization of an Antifreeze Protein Gene, TaAFPIII, from Wheat (Triticum aestivum),” came from the same group we wrote about in April 2012 when they retracted a paper from Acta Biochimica et Biophysica Sinica, also about genetically altered wheat.
At the time, the authors said they were pulling the other paper because they were having trouble replicating their findings. That now seems accurate, but not entirely complete.
As the new retraction notice states: Continue reading A retraction with “serious consequences to wheat production”
“Unfinished business”: Diederik Stapel retraction count rises to 53
Two more papers by Diederik Stapel — who was profiled by The New York Times Magazine this weekend — have been retracted, both in the Journal of Experimental Social Psychology.
The notice for “Hardly thinking about close and distant others: On cognitive business and target closeness in social comparison effects,” by Stapel and David Marx, and cited six times: Continue reading “Unfinished business”: Diederik Stapel retraction count rises to 53
Retraction appears for former Case Western dermatology researcher found by ORI to have falsified data
Bryan William Doreian, who was found by the Office of Research Integrity (ORI) to have falsified data in his Case Western dissertation, has retracted a 2009 paper in Molecular Biology of the Cell also cited by the ORI.
Here’s the notice: Continue reading Retraction appears for former Case Western dermatology researcher found by ORI to have falsified data